Home›Companies›Healthcare›INCOG BioPharma Services

INCOG BioPharma Services, Inc.

Updated Oct 27, 2026·Latest SEC filing May 29, 2024·Suggest an edit

About INCOG BioPharma Services

INCOG BioPharma Services is a private company based in Fishers, Indiana, incorporated in 2020 in Delaware. It has reported $86,630,252 raised in three offerings on Form D since September 2020. Its chief executive is Cory Lewis.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
May 14, 2024May 29, 2024amended May 29, 2024$42,864,002fully sold1$42.8MEquityRule 506(b)Form D/A ↗1 earlier filing
Apr 26, 2022May 10, 2022$14,999,250of $25.0M target5$2.9MEquity, DebtRule 506(b)Form D ↗
Sep 3, 2020Sep 29, 2020$28,767,000of $51.0M target3$9.5MEquity, DebtRule 506(b)Form D ↗
Total, three offerings$86,630,252

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on INCOG BioPharma Services's Form D filed May 29, 2024.

TG
Tedd Green
Executive officer
DD
Doug Dayoff
Executive officer
CL
Cory Lewis
Chief Executive Officer and director
KB
Karen Blair
Director
KS

Earlier filings also listed Martin Van Trieste (director, last listed May 2022).

Sources

  1. SECINCOG BioPharma Services, Inc. Form D, filed May 29, 2024
  2. SECINCOG BioPharma Services, Inc. filing history